Improved synthesis of fenofibrate as lipid-lowering drug

被引：0
|
作者：
Man, Lili [1 ]
Li, Shuliang [2 ]
Yang, Hanyue [2 ]
Yan, Xianguang [2 ]
Dong, Shubo [2 ]
Zhang, Zhenming [3 ]
机构：
[1] School of Pharmacy, Jiangsu Ocean University, Jiangsu, Lianyungang,222005, China
[2] Jiangsu Deyuan Pharmaceutical Co., Ltd., Jiangsu, Lianyungang,222047, China
[3] School of Environmental and Chemical Engineering, Jiangsu Ocean University, Jiangsu, Lianyungang,222005, China
来源：
Jingxi Huagong/Fine Chemicals | 2023年 / 40卷 / 07期
关键词：
D O I：
10.13550/j.jxhg.20220880
中图分类号：
学科分类号：
摘要：
22
引用
收藏
页码：1505 / 1512
相关论文
共 50 条
  • [1] Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug
    Lee, Jung-Jin
    Jin, Yong-Ri
    Yu, Ji-Yeon
    Munkhtsetseg, Tudev
    Park, Eun-Seok
    Lim, Yong
    Kim, Tack-Joong
    Pyo, Myoung-Yun
    Hong, Jin Tae
    Yoo, Hwan-Soo
    Kim, Youngsoo
    Yun, Yeo-Pyo
    ATHEROSCLEROSIS, 2009, 206 (02) : 375 - 382
  • [2] Fenofibrate - A lipid-lowering drug - Reduces voluntary alcohol drinking in rats
    Karahanian, Eduardo
    Quintanilla, Maria Elena
    Fernandez, Katia
    Israel, Yedy
    ALCOHOL, 2014, 48 (07) : 665 - 670
  • [3] Rosuvastatin - A new lipid-lowering drug
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1167): : 81 - 83
  • [4] Pitavastatin: a distinctive lipid-lowering drug
    Ose, Leiv
    CLINICAL LIPIDOLOGY, 2010, 5 (03) : 309 - 323
  • [5] New indications for lipid-lowering drug
    不详
    GERIATRICS, 1996, 51 (12) : 24 - 24
  • [6] Lipid-lowering drug therapies: the evidence
    Packard, C
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2000, 59 (03) : 423 - 424
  • [7] LIPID-LOWERING DRUG-THERAPY
    GRETEN, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (36) : 1395 - 1395
  • [8] Fenofibrate, probucol, and other lipid-lowering treatments in heart transplant recipients
    deLorgeril, M
    Boissonnat, P
    Salen, P
    Monjaud, I
    Dureau, G
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1996, 15 (05): : 539 - 540
  • [9] The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas
    Zhu, Wei
    Zhao, Hongyang
    Xu, Fenfen
    Huang, Bin
    Dai, Xiaojing
    Sun, Jikui
    Nyalali, Alphonce M. K.
    Zhang, Kailiang
    Ni, Shilei
    BMC CANCER, 2021, 21 (01)
  • [10] The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas
    Wei Zhu
    Hongyang Zhao
    Fenfen Xu
    Bin Huang
    Xiaojing Dai
    Jikui Sun
    Alphonce M. K. Nyalali
    Kailiang Zhang
    Shilei Ni
    BMC Cancer, 21
12345